Skip to main content
Clinical Trials/NCT02925637
NCT02925637
Completed
N/A

Effectiveness of a Novel Meta-cognitive-functional Intervention (FACoT) for Individuals Post Mild-moderate Stroke

Bait Balev Hospital1 site in 1 country66 target enrollmentMarch 12, 2017
ConditionsStroke

Overview

Phase
N/A
Intervention
Not specified
Conditions
Stroke
Sponsor
Bait Balev Hospital
Enrollment
66
Locations
1
Primary Endpoint
Change in scores of The Canadian Occupational Performance Measure (COPM)
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

To develop and assess the effectiveness of a novel cognitive-functional intervention (FACoT) in occupational therapy for people after mild to moderate stroke.

Registry
clinicaltrials.gov
Start Date
March 12, 2017
End Date
February 27, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Bait Balev Hospital
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • with no other neurological or psychiatric conditions
  • without dementia

Outcomes

Primary Outcomes

Change in scores of The Canadian Occupational Performance Measure (COPM)

Time Frame: Change between baseline (week 0) to time 1 (post-intervention -10-13 weeks later) and time 2 (follow-up- three month later)

Secondary Outcomes

  • Change in scores of Reintegration to Normal Living Index (RNL)(Change between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up-3 month later))
  • Change in scores of Short Form-12v2 Health Survey (SF-12v2)(Change between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up- 3 month later))
  • Change in scores of zoo-map(Change between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up-3 month later))
  • Change in scores of the Instrumental Activities of Daily Living (IADL) scale(Change between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up- 3 month later))
  • change in scoe of New general self efficacy scale (NGSE)(Change between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up- 3 month later))
  • Change in scores of Patient competency rating scale (PCRS)(Change between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up- 3 month later))
  • Change in scores Self Regulation Skills Interview (SRSI)(Change between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up- 3 month later))
  • Change in scores of Montreal Cognitive Assessment (MoCA)(Change between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up-3 month later))
  • Change in scores of Trail making test (TMT)(Change between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up- 3 month later))
  • Change in scores of Dysexecutive Questionnaire (DEX)(Change between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up- 3month later))
  • Geriatric Depression Scale - short form (GDS-SF)(Change between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up- 3 month later))

Study Sites (1)

Loading locations...

Similar Trials